Diamyd Medical AB (publ) (DMYD-B) — Working Capital to Net Assets Ratio
Diamyd Medical AB (publ) (DMYD-B) has a Working Capital to Net Assets ratio of 127.0% as of May 2026. Working capital of Skr329.46 Million (current assets of Skr352.18 Million minus current liabilities of Skr22.72 Million) is measured against net assets of Skr259.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Diamyd Medical AB (publ) to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Diamyd Medical AB (publ) Working Capital to Net Assets (2010–2025)
This chart shows how Diamyd Medical AB (publ)'s Working Capital to Net Assets ratio has evolved across 16 annual periods from 2010 to 2025. As of May 2026, the ratio stands at 127.0%, reflecting working capital of Skr329.46 Million against net assets of Skr259.39 Million SEK. For the complete balance sheet picture, see DMYD-B current and non-current assets.
Annual Working Capital to Net Assets for Diamyd Medical AB (publ) (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Diamyd Medical AB (publ) from 2010 to 2025, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check DMYD-B asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 94.6% | Skr264.92 Million | Skr280.00 Million | Skr292.40 Million | Skr27.48 Million | ▲ +13.0 pp |
| 2024 | 81.6% | Skr119.12 Million | Skr145.92 Million | Skr159.14 Million | Skr40.02 Million | ▲ +10.2 pp |
| 2023 | 71.4% | Skr120.95 Million | Skr169.40 Million | Skr140.81 Million | Skr19.85 Million | ▲ +0.7 pp |
| 2022 | 70.7% | Skr151.64 Million | Skr214.38 Million | Skr173.01 Million | Skr21.37 Million | ▼ -9.4 pp |
| 2021 | 80.1% | Skr151.57 Million | Skr189.26 Million | Skr162.97 Million | Skr11.40 Million | ▲ +3.0 pp |
| 2020 | 77.1% | Skr55.90 Million | Skr72.49 Million | Skr72.39 Million | Skr16.50 Million | ▼ -4.5 pp |
| 2019 | 81.6% | Skr51.23 Million | Skr62.78 Million | Skr61.88 Million | Skr10.64 Million | ▼ -4.0 pp |
| 2018 | 85.6% | Skr36.83 Million | Skr43.01 Million | Skr47.19 Million | Skr10.36 Million | ▼ -8.6 pp |
| 2017 | 94.3% | Skr81.68 Million | Skr86.67 Million | Skr91.07 Million | Skr9.39 Million | ▼ -0.2 pp |
| 2016 | 94.5% | Skr27.65 Million | Skr29.26 Million | Skr32.95 Million | Skr5.30 Million | ▲ +33.3 pp |
| 2015 | 61.2% | Skr24.19 Million | Skr39.52 Million | Skr30.50 Million | Skr6.32 Million | ▼ -9.4 pp |
| 2014 | 70.6% | Skr31.20 Million | Skr44.16 Million | Skr37.21 Million | Skr6.02 Million | ▼ -29.5 pp |
| 2013 | 100.1% | Skr60.36 Million | Skr60.29 Million | Skr67.09 Million | Skr6.73 Million | ▲ +7.7 pp |
| 2012 | 92.5% | Skr378.67 Million | Skr409.58 Million | Skr390.05 Million | Skr11.38 Million | ▲ +2.9 pp |
| 2011 | 89.6% | Skr412.88 Million | Skr460.97 Million | Skr471.51 Million | Skr58.63 Million | ▲ +4.9 pp |
| 2010 | 84.7% | Skr266.62 Million | Skr314.78 Million | Skr521.03 Million | Skr254.41 Million | — |